KORE and Able Device Announce Agreement to Deploy Enterprise Customer Pilots for SIMbae™
KORE, the people powering the Internet-of-Things (IoT) innovations and opportunities, and Able Device, a pioneer in SIM-based IoT and M2M application technology, today announced an agreement to deploy enterprise customer pilots that embed Able Device’s flagship offering, SIMbae, on KORE IoT SIMs (Subscriber Identity Modules). SIMbae, a new and innovative SIM-based solution utilizes established 3GPP standards and provides valuable tools on KORE SIMs to solve common IoT device deployment issues related to network connectivity, commercial and service requirements, and data roaming.
“Large scale deployments of IoT services, particularly global services, must be driven with greater ease and reliability of roll out,” said Alex Brisbourne, KORE CEO. “The goal is to move as close as possible to plug and play deliveries as well as simplified, automated, service connectivity around the globe. A perfect complement to our subscription management/eSIM solutions which already have over 1.2m connections depending upon it, integrating SIMBae provides a further level of automated service assurance,” concluded Brisbourne.
With deployments beginning in March 2017, customer pilots will initially center around three IoT use cases:
- The first case focuses on troubleshooting an IoT device that is not reporting into the server. In this scenario, SIMbae reports mobile-specific network information such as signal strength, neighboring cells, and other key metrics to determine the connectivity issue.
- A second case addresses an IoT device roaming onto a network that doesn’t meet commercial or service requirements and is then resolved through implementing SIMbae’s Dynamic PLMN Manager.
- The third scenario deployed during the pilots will utilize SIMbae’s Packet Data Reporter to change networks when a device roams onto a network that doesn’t support data roaming. Additionally, by embedding these tools on KORE’s SIMs and utilizing 3GPP standards, a consistent high level of application and communications security is achieved.
“We’re extremely excited to enter into real world, enterprise commercial pilots with KORE as they were the first service provider we approached when SIMbae was conceived,” stated Roger Dewey, CEO and Founder of Able Device. “The reason for this was KORE’s strong vision and early leadership in offering the enterprise market high value services to deploy IoT projects in a very flexible model.” He continued by saying, “Able Device and KORE share a philosophy centered on ease of development, deployment, security, and operation for mobile IoT applications. The standard SIM is the perfect vehicle for realizing that vision on a mass scale, but the SIM is not enough as it needs to be coupled with enterprise centric services.”
To visit with KORE during Mobile World Congress 2017 to learn more about these new and innovative SIM-based tools and how can they can simplify and secure your IoT deployments, contact Jacqueline Tait at email@example.com.
KORE provides the connectivity and services that make the Internet of Things possible. Founded in 2003, KORE is the world’s largest managed network services provider specializing in Internet of Things (IoT) and Machine to Machine (M2M) markets. KORE provides the critical wireless IoT connectivity empowering application, hardware and wireless operator partners to rapidly bring new IoT and M2M innovations to market, with millions of active on-network units in more than 180 countries. KORE delivers choice, reliability and global native coverage through multi-carrier and Tier 1 carrier cellular and satellite network services – including LTE, GSM and CDMA - as well as advanced applications to easily manage IoT connected devices. KORE Position Logic software provides seamless location-based services (LBS) for businesses. KORE’s recent acquisition of Wyless makes the company one of the six largest providers of M2M/IoT services globally, inclusive of carriers.
About Able Device
Able Device is a provider of technology for Mobile Network Operators (MNOs) and IoT service providers. Its flagship product SIMbae™ (short for "SIM based application engine") enables hosting of IoT device controls and applications on standard SIMs. In this new architecture, the SIM is transformed to an intelligent independent processor. As SIMbae utilizes established and common 3GPP SIM standards, IoT controls and applications implemented this way become device and carrier agnostic - with benefits including shorter time to market, reduced development cost, lower operating cost, and improved security. Based in Raleigh, NC, Able Device serves mobile network operators globally.
For more information, visit www.abledevice.com.
All products/services and trademarks mentioned in this release are the properties of their respective companies.
Om Business Wire
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Celltrion Receives Positive CHMP Opinion for Herzuma® for Trastuzumab Biosimilar15.12.2017 22:13 | Pressemelding
Celltrion, Inc. (KOSDAQ: 068270) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending that Herzuma® (trastuzumab biosimilar) be granted marketing authorization in the European Union (EU) for the treatment of patients with early breast cancer, metastatic breast cancer, or metastatic gastric cancer whose tumors have either HER2 overexpression or HER2 gene amplification. The CHMP’s opinion will now be sent to the European Commission (EC) for final review. Herzuma® is a biosimilar to Herceptin®i, a breast cancer and gastric cancer treatment antibody biologic drug developed by Genentech and marketed by Roche. Herceptin® is a blockbuster drug which had worldwide sales of CHF 6.8 billionii (US$6.8 billion) in 2016, of which CHF 2.1 billioniii (US$2.1 billion) was in
Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease15.12.2017 12:34 | Pressemelding
Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and TiGenix NV (Euronext Brussels and NASDAQ: TIG) (“TiGenix”) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), in conjunction with the Committee for Advanced Therapies (CAT), has adopted a positive opinion recommending a marketing authorization (MA) for investigational compound Cx601 (darvadstrocel). Cx601 is expected to be indicated for the treatment of complex perianal fistulas in adult patients with non-active/mildly active luminal Crohn’s disease, when fistulas have shown an inadequate response to at least one conventional or biologic therapy.2 This recommendation marks the first allogeneic stem cell therapy to receive a positive CHMP opinion in Europe. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/201712
Bitcoin Romania and Twispay Announce Integration Partnership Providing Users with the Ability to Purchase Bitcoin with Bank Cards15.12.2017 12:21 | Pressemelding
Bitcoin Romania, leading Eastern European Bitcoin exchange & brokerage firm, and Twispay, Swiss-owned European payment processor and FinTech pioneer, today announced the availability of a payment integration that allows a global clientele to acquire Bitcoin and Ethereum cryptocurrencies using Visa and Mastercard bank cards. Unprecedented in Romania, this is one of the first East-Central European integration partnerships that allow consumers to use their cards to purchase cryptocurrency. Until recently, investors could only acquire cryptocurrencies through bank transfers and cash deposits, but the volatility of cryptocurrency markets dictates the need for additional operational flexibility. Investors require faster, safer, more reliable, and more comfortable ways to complete purchases. “One minute can make the difference between a million lost and a million earned. That is pr
Upon Conclusion of the Fourth Annual Forum for Promoting Peace in Muslim Societies, Scholars and Intellectuals Visit the Louvre Abu Dhabi Museum15.12.2017 11:38 | Pressemelding
A high-level delegation of dignitaries, scholars and intellectuals participating in the fourth annual Forum for Promoting Peace in Muslim Societies, visited the Louvre Abu Dhabi museum. The delegation was headed by H.E Mustafa Ceric, former Grand Mufti of Bosnia; alongside Sheikh Mohammad Mukhtar Ould Imbala, Head of Mauritania’s Fatwa & Grievances Supreme Council; H.E Amar Mirghani Hussein, Sudanese Minister of (religious) Guidance and Endowments; and H.E Salho Jay, Imam of the Juma Masjid in South Africa. The Forum was held in Abu Dhabi from 11-13 December 2017, with the participation of more than 700 scholars, intellectuals and religious dignitaries from around the world. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171215005255/en/ Group Photo of the Scholars and Intellectuals during their visit to the L
Kennedy Wilson Acquires 124-Unit Northbank Apartments in Dublin, Ireland for €45 Million15.12.2017 11:00 | Pressemelding
Global real estate investment company Kennedy Wilson (NYSE: KW) announces that it has acquired Northbank Apartments, a wholly-owned 124-unit apartment community in Dublin’s North Docks, for €45 million from Jarmar Properties Limited (In Receivership) acting through David Carson of Deloitte as Statutory Receiver, the lender being the National Asset Management Agency (“NAMA”). Situated in Dublin’s North Docks, Northbank is located just 50 meters from Kennedy Wilson’s existing 84-unit Liffey Trust apartments. The two buildings benefit from great transport links as the LUAS Red line is immediately adjacent connecting to Dublin’s city centre and main train stations in five minutes. “The successful acquisition of Northbank in such close proximity to our Liffey Trust asset allows us to leverage our existing presence and implement our value-add asset management strategy, including a
AML BitCoin Enters Phase II of ICO15.12.2017 09:00 | Pressemelding
NAC Foundation, LLC announces today that the initial coin offering for the AML BitCoin – the world’s only patent-pending compliant digital currency – has been extended for another month to accommodate a torrent of last minute, new coin purchasers and the demands of thousands of current owners of the coin, who have had difficulty navigating the process of establishing the specialized wallet required to hold the innovative digital currency. This second phase of the AML BitCoin initial coin offering will see an increase in the price of the coin, from US $1.00 to US $1.25. The company has already been contacted by prospective purchasers in the slightly higher priced Phase II, and anticipates a further price increase to US $1.50 within a week or two. HitBTC, one of the world’s largest and most active digital currency exchanges, was prepared to list the AML BitCoin for trading on
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom